High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

By Alexander G. Logana, Sandra M. Perlikowskia, Andrew Mentea, András Tisléra, Ruzena Tkacovab, Mitra Niroumandb, Richard S.T. Leungb, D. Bradleyb. Journal of Hypertension, 2001

961 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Experimental and Cognitive Psychology, Physiology

View Paper: https://www.semanticscholar.org/paper/9d5b0dbbcd36664dd1021d4131a38baca4d29ccc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Virend K. Somers
2. Berk Ustun
3. S. Daniels
4. Cynthia Rudin

In Experimental and Cognitive Psychology

1. Cynthia Rudin
2. Berk Ustun
3. T. Young
4. Paul E. Peppard
5. J. Floras
6. Naresh M. Punjabi
7. D. Gottlieb
8. Tong Wang

In Physiology

1. Cynthia Rudin
2. T. Young
3. Berk Ustun
4. Paul E. Peppard
5. Virend K. Somers
6. J. Floras
7. J. Skatrud
8. Naresh M. Punjabi

Citations in the corpus

• Risk factors for obstructive sleep apnea in adults. (2004, background): “Obstructive sleep apnea is particularly common in patients with resistant hypertension; in a study of patients with hypertension, unsuspected sleep apnea was noted in 83% of those with resistant hypertension, defined as poorly controlled hypertension despite the use of 3 or more antihypertensive age”
• Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. (2013, neutral): “TSat90, median (IQR) 9 (2-20) 8 (2-19) 9.”
• Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun (2008, background): “To determine the interaction between OSA in patients with drug-resistant hypertension, defined as a clinic BP of 140/ 90 mm Hg while taking a combination of 3 antihypertensive drugs titrated to maximally recommended doses, Logan et al (145) noted that the prevalence of OSA, defined as an AHI of 10, ”
• Clinical Prediction Models for Sleep Apnea: The Importance of Medical History over Symptoms (2016, positive): “14 OSA risk prediction models that utilize demographic and comorbidity information are advantageous in that they can make predictions from electronic health records without drawing on the limited resources available for direct patient care encounters.”